Eating peanuts daily in adults using GLP-1 weight-loss medicines
Tests daily peanuts for 12 weeks in adults taking GLP-1 medicines.
Key facts
- Who runs it
- Ian J. Neeland, MD
- Where
- Clevland, United StatesSee the site
- Trial code
- Registry title
- Dietary Peanuts and Nutrition-Related Outcomes
- Status
- Recruiting
- People taking part
- 64 people, planned
- Started
- 20 Apr 2026
- Expected to end
- Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Peanuts
- Dual-energy X-ray absorptiometry (DEXA) scans
- Record updated
- 23 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who use semaglutide or tirzepatide and have a high body weight. People will add peanuts to their meals for 12 weeks.
- Age
- 18 to 80 years
- Sex
- All sexes can join.
- Disease stage
- BMI of 30 kg/m2 or more, or BMI of 27 kg/m2 or more with at least one health problem related to weight.
- Earlier treatment
- Must be using semaglutide or tirzepatide for a clinical indication or for at least 6 months.
Main reasons for not taking part
- Not using a GLP-1 RA, or cannot use one
- Known allergy to nuts
- Pregnant or breastfeeding
- Incarcerated
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Individuals with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 with at least one weight-related comorbidity who have been using semaglutide or tirzepatide for a clinical indication or at least 6 months
Who cannot take part
- Known allergy to nuts
- No use or contraindication to use of a GLP-1 RA
- Pregnant or breastfeeding
- Incarcerated
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in United States
- University Hospitals Cleveland Medical CenterClevland, United StatesContact: Ian Neeland, MDTaking people
About the trial
What the trial wants to find out
This study will look at how eating peanuts every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding peanuts to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating peanuts improves overall diet quality and health markers like tiredness and certain levels in blood.
The 2 groups in the trial
- Peanut GroupTreatment being tested
Participants in this group will eat 2 ounces, or 53 grams of dry-roasted, lightly salted (low sodium) each day along with their regular diet.
Treatment: Peanuts and Dual-energy X-ray absorptiometry (DEXA) scans
- No Peanut GroupExisting treatment, for comparison
Participants in this group will continue eating regular diet without peanuts.
Treatment: Dual-energy X-ray absorptiometry (DEXA) scans
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Dietary Peanut Intake and Nutrition-Related Outcomes in Individuals Using GLP-1 Receptor Agonists: A Randomized Controlled Trial
- Plain-language title
- Eating peanuts daily in adults using GLP-1 weight-loss medicinesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07244458, who can take part
- Record updated
- 23 April 2026